SCIENTIFIC NEWS AND
INNOVATION FROM ÉTS
MIT’s Approach to Ensuring the Profitability of its Intellectual Property Portfolio - By : Lotfi Chouanine,

MIT’s Approach to Ensuring the Profitability of its Intellectual Property Portfolio


Lotfi Chouanine
Lotfi Chouanine Author profile
Lotfi Chouanine is a research advisor at ÉTS. He holds a Ph.D. from the University of Ibaraki (Japan), an MBA from UQÀM (Canada) and a Master’s degree from the University of Volgograd (Russia).

Christopher Noble of the Massachusetts Institute of Technology (MIT) gave a lecture at the École de technologie supérieure (ÉTS) in Montreal on Thursday, June 8, 2017, in which he explained how MIT manages intellectual property portfolio and entrepreneurship. He is a technology licensing officer responsible for MIT’s energy technology and for supporting some of MIT’s key international partnerships. A Montreal native, he was pleased to accept the conference offer made by Lotfi Chouanine, a research advisor at the École de technologie supérieure (ÉTS) in Montreal.

From this conference, we propose a series of four articles to clarify:

  1. How MIT encourages students and faculty to start businesses;
  2. Its approach to patents and the management of intellectual property;
  3. Its intellectual property (IP) policy;
  4. How MIT manage to create business ties between large companies and start-up companies.

The first article in this series described how MIT encourages students and professors to start new businesses following the example of LiquiGlide, Inc., established in 2017. The second article outlined the intellectual property management process used by MIT with regard to the technology transfer cycle. This third article explains how MIT succeeded in making its IP portfolio profitable.

_____________________________________

MIT’s IP Portfolio

One observation that may seem surprising is that MIT now conducts more research in the life sciences than in the physical sciences! Usually, much of the life science research is conducted at universities with medical schools. MIT has no medical school but is fortunate to have half a dozen major university hospitals in the Boston area. The partnerships established with these hospitals have helped increase the amount of life science research at MIT, as shown in the figure below. Research in the fields of software engineering and computer hardware represents only 10% each of the IP portfolio.

MIT’s researchers file about 800 invention disclosures per year. The research budget is approximately US $1 billion, of which $750 million goes to the main campus. Each research leading to an invention disclosure requires about $1 million in research funds. This ratio has risen steadily over the past decade.

Generally speaking, one-third of the invention disclosures are patented. The other two-thirds may not be suited for a patent application or have not been accepted by the Technology Licensing Office.

Approximately 50% of MIT’s IP-patents portfolio is licensed for technology transfer, meaning that the other 50% of patents has not been licensed to a company or a start-up. Scientific research produces about 100 licenses per year at MIT. One-third of these licenses are signed with MIT’s start-ups.

In summary, of the 800 invention disclosures filed annually, 400 to 500 make patent applications; approximately 200 patent applications are granted and, of those, MIT’s Technology Licensing Office grants 100 technology transfer licenses, one-third of which are signed with MIT’s start-ups.

Unprofitable Technology Transfers

What MIT and many other universities acknowledge is that technology transfers should not be considered as an income-generating resource. They generate great benefits for universities but, with a few exceptions, technology transfer is generally not profitable [1]. According to the Brookings Institution Report, “with 84% universities operating technology transfer in the red, 2012 was a good year because over the last 20 years, on average, 87% did not break even” [2, p. 9].

In addition, income from technology transfers is widely distributed: inventors typically receive one-third of revenues, the laboratory or department, a second third, and the last third go to the university [2, p. 9].

Is technology transfer really worth it for a university?

The Added Value of Technology Transfer at MIT

Commercialization of technology transfer licenses to companies plays a dual role for MIT:

  1. Acquire patent licenses for businesses;
  2. Encourage companies to invest (and reinvest) in research, thus increasing MIT’s research budget to create inventions that will generate more IP.

This is how MIT is able to make the most of technology transfers.

Next Article

Large corporations do not really know how to build business relationships with start-up companies. Some of them invest in start-ups and buy them out when they are successful; others ignore start-ups, not knowing what’s in it for them. MIT has found a way to create business ties between large corporations and start-up companies, to the extent that some large corporations have decided to move their headquarters to be closer to these start-ups…

Lotfi Chouanine

Author's profile

Lotfi Chouanine is a research advisor at ÉTS. He holds a Ph.D. from the University of Ibaraki (Japan), an MBA from UQÀM (Canada) and a Master’s degree from the University of Volgograd (Russia).

Author profile


Get the latest scientific news from ÉTS
comments

    Leave a Reply

    Your email address will not be published. Required fields are marked *